ZA951575B - Use of a tricyclic compound for obtaining medicinal products intended for the treatment of memory/cognitive disorders - Google Patents
Use of a tricyclic compound for obtaining medicinal products intended for the treatment of memory/cognitive disordersInfo
- Publication number
- ZA951575B ZA951575B ZA951575A ZA951575A ZA951575B ZA 951575 B ZA951575 B ZA 951575B ZA 951575 A ZA951575 A ZA 951575A ZA 951575 A ZA951575 A ZA 951575A ZA 951575 B ZA951575 B ZA 951575B
- Authority
- ZA
- South Africa
- Prior art keywords
- memory
- treatment
- cognitive disorders
- medicinal products
- tricyclic compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9402160A FR2716623B1 (fr) | 1994-02-25 | 1994-02-25 | Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA951575B true ZA951575B (en) | 1995-12-12 |
Family
ID=9460422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA951575A ZA951575B (en) | 1994-02-25 | 1995-02-24 | Use of a tricyclic compound for obtaining medicinal products intended for the treatment of memory/cognitive disorders |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0671173A1 (de) |
| JP (1) | JPH07258089A (de) |
| CN (1) | CN1051226C (de) |
| AU (1) | AU684880B2 (de) |
| CA (1) | CA2143251A1 (de) |
| FI (1) | FI950725A (de) |
| FR (1) | FR2716623B1 (de) |
| NO (1) | NO950714L (de) |
| NZ (1) | NZ270566A (de) |
| ZA (1) | ZA951575B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2747921B1 (fr) * | 1996-04-24 | 1998-10-30 | Adir | Comprime matriciel permettant la liberation prolongee du sel de sodium de tianeptine apres administration par voie orale |
| FR2791891A1 (fr) * | 1999-04-07 | 2000-10-13 | Adir | Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence |
| FR2807039A1 (fr) * | 2000-03-31 | 2001-10-05 | Adir | NOUVEAU PROCEDE DE PREPARATION DE LA 11-AMINO-3-CHLORO-6,11- DIHYDRO-5,5-DIOXO-6-METHYL-DIBENZO[c,f][1,2]-THIAZEPINE ET APPLICATION A LA SYNTHESE DE LA TIANEPTINE |
| JP2010520298A (ja) * | 2007-03-05 | 2010-06-10 | トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド | ７−［（３−クロロ−６，１１−ジヒドロ−６−メチルジベンゾ［ｃ，ｆ］［１，２］チアゼピン−１１−イル）アミノ］ヘプタン酸Ｓ，Ｓ−ジオキシドの多形相ならびにそれらの製造及び使用方法 |
| US8198268B2 (en) | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
| WO2010070667A2 (en) * | 2008-11-19 | 2010-06-24 | Biophore India Pharmaceuticals Pvt. Ltd. | Novel process for the preparation of 7-((3-chloro-6-methyl-5,5-dioxo-6,11-dihydrodibenzo(c,f)(1,2) thiazepin-11-yl)amino)heptanoate |
| US8355927B2 (en) | 2010-11-05 | 2013-01-15 | Genomind, Llc | Neuropsychiatric test reports |
| KR102199871B1 (ko) | 2018-12-21 | 2021-01-08 | 주식회사 한서켐 | 3,11-디클로로-6-메틸-6,11-디하이드로디벤조[c,f][1,2]티아제핀 5,5-디옥시드의 제조방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1269551A (en) | 1969-03-27 | 1972-04-06 | Science Union & Cie | New tricyclic derivatives and process for their manufacture |
| CH629667A5 (fr) * | 1978-03-28 | 1982-05-14 | Science Union & Cie | Composition pharmaceutique agissant sur la motricite gastro-intestinale. |
| FR2635461B1 (fr) * | 1988-08-18 | 1992-01-17 | Adir | Utilisation de derives tricycliques pour l'obtention de medicaments destines au traitement du stress |
-
1994
- 1994-02-25 FR FR9402160A patent/FR2716623B1/fr not_active Expired - Fee Related
-
1995
- 1995-02-17 FI FI950725A patent/FI950725A/fi unknown
- 1995-02-23 CA CA002143251A patent/CA2143251A1/fr not_active Abandoned
- 1995-02-23 EP EP95400383A patent/EP0671173A1/de not_active Withdrawn
- 1995-02-24 JP JP7036489A patent/JPH07258089A/ja active Pending
- 1995-02-24 CN CN95102146A patent/CN1051226C/zh not_active Expired - Fee Related
- 1995-02-24 NZ NZ270566A patent/NZ270566A/en unknown
- 1995-02-24 NO NO950714A patent/NO950714L/no unknown
- 1995-02-24 AU AU13488/95A patent/AU684880B2/en not_active Ceased
- 1995-02-24 ZA ZA951575A patent/ZA951575B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2143251A1 (fr) | 1995-08-26 |
| FI950725A0 (fi) | 1995-02-17 |
| JPH07258089A (ja) | 1995-10-09 |
| NZ270566A (en) | 1996-01-26 |
| AU1348895A (en) | 1995-09-07 |
| FI950725A (fi) | 1995-08-26 |
| CN1051226C (zh) | 2000-04-12 |
| CN1119100A (zh) | 1996-03-27 |
| NO950714D0 (no) | 1995-02-24 |
| AU684880B2 (en) | 1998-01-08 |
| FR2716623A1 (fr) | 1995-09-01 |
| FR2716623B1 (fr) | 1996-08-23 |
| EP0671173A1 (de) | 1995-09-13 |
| NO950714L (no) | 1995-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL116998A0 (en) | Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders | |
| HK1008180A1 (en) | Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism | |
| GB2301537B (en) | Two-component device for the administration of drugs | |
| HUP9904525A3 (en) | Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan | |
| NO306977B1 (no) | Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen | |
| GB9421709D0 (en) | Therapeutic compounds | |
| HK1003711A1 (en) | Therapeutic compounds | |
| GB2292079B (en) | Coated prednisolone preparation for the treatment of inflamatory bowel disease | |
| ZA951575B (en) | Use of a tricyclic compound for obtaining medicinal products intended for the treatment of memory/cognitive disorders | |
| SG45104A1 (en) | Process for the preparation of ammoxidation catalysts | |
| IL121329A0 (en) | A pharmaceutical composition for the treatment of cancer | |
| GB9518887D0 (en) | Treatment of muscular disorders | |
| AU4081393A (en) | Medicaments for the treatment of anxiety | |
| ZA932450B (en) | Drugs for the treatment of diabetes | |
| GB2272155B (en) | Piperazine derivatives for treatment of cognitive disorders | |
| EP0724842A3 (de) | Präparat zur Behandlung der Fettsucht | |
| GB9420080D0 (en) | The treatment of liquids | |
| IL107515A (en) | Diagnosis of mental disorders | |
| ZA945651B (en) | Use of benzenesulphonzlindole derivatives for the preparation of medicines | |
| ZA944671B (en) | Medicaments for the treatment of inflammatory diseases | |
| EP0692259A3 (de) | Verwendung von HCG-spezifischen Antikörpern für die Behandlung von Gehirnneoplasmen | |
| EP0494002A3 (en) | Use of certain esters of hexahydro-8-hydroxy-2, 6-methano-2h-quinolizin-3(4h)-one and related compounds for the preparation of medicaments for treating cognitive disorders | |
| EP0579077A3 (en) | 1,3,4-thiadiazinones for the treatment of cardiovascular diseases | |
| ZA95511B (en) | Treatment of anorectal disorders | |
| GB9324852D0 (en) | A medicament for the treatment of metasteses |